submission offalse claims for Lipitor, Aecupril and other drugs.
McNeil and Omnicare conspired to defraud the govemment by submitting false claims and
causing the submission of false claims for Levaquin, Ultram/Ultracet, and other drugs.
By effectuating a similar PAL letter solicitation-for-kickback scheme, Janssen and
Omnicare conspired to defraud the government by submitting false claims and causing the
submission of false claims for Risperdal and other drugs.
As a result of the claims for reimbursement defendants caused to be submitted to
Medicaid, which were certified compliant with federal and state Medicaid law and regulation as
a condition of payment by co-conspirator pharmacies, the government regularly made payments
to pharmacies for Defendant Manufacturers' illegally switched drugs.
The amounts of the false or fraudulent claims to the government were material.
Plaintiff United States, being unaware of the falsity of the claims and/or
statements caused to be made by the Defendant Manufacturers, and in reliance on the accuracy
thereof paid and may continue to pay for the Defendant Manufacturers' improperly switched
termination with Omnicare.
above, the government has been damaged in an amount that is believed to be in excess of $3.5
million from Omnicare's northern Illinois facilities alone. As the Defendant Manufacturers' and
Omnicare's fraudulent practices extend throughout the country to states where government
reimbursement rates make such fraud lucrative for the Defendant Manufacturers; the amount of
total damages to the government exceeds $10 million.